The litigation involves a patent granted to Novozymes in November 2009. The company already won a similar case against Danisco in Denmark on March 4.
Novozymes says it is now entitled to an immediate injunction against Danisco in the Netherlands in relation to the infringement there.
“Novozymes is aggressively protecting its patents across the world and also in the Netherlands,” said Mikkel Viltoft, general counsel for Novozymes, in an e-mailed statement.
“Although the Netherlands isn’t one of the most important markets for this product, we are happy with the outcome. This decision sets an important precedent.”
US-based Danisco officials were not immediately available to comment.